Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance

Detalhes bibliográficos
Autor(a) principal: Ferreira,Cristina Nunes
Data de Publicação: 2016
Outros Autores: Fahham,Lucas de Vasconcelos, Santana,Carlos Felipe Salgado de, Rio,João Carlos Elias, Mazza,Débora Dutra da Silveira, Squiassi,Haline Bianca
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Dor
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400294
Resumo: ABSTRACT BACKGROUND AND OBJECTIVES: Adequate postoperative pain and renal colic control is critical for patients' recovery and to decrease hospitalization costs and the use of resources. So, this study aimed at evaluating hospitalization time of patients treated with parecoxib sodium versus other non-steroid anti-inflammatory drugs to manage postoperative pain of appendectomy or fractures and renal colic. METHODS: This is a retrospective data analysis of Brazilian private hospitals medical bills, including patients treated with non-steroid anti-inflammatory drugs to decrease post-appendectomy pain (n=1618), post orthopedic fracture pain (n=2858 and renal colic (n=6555), between January and June 2014. Mean hospitalization time was evaluated according to each group of drugs. Mean difference among groups was calculated by the Kruskal-Wallis method. RESULTS: Mean hospitalization time for patients submitted to appendectomy was 1.95 days with parecoxib versus 2.20 with other non-steroid anti-inflammatory drugs (p= 0.006). For patients submitted to orthopedic fracture surgery, mean time was 1.75 days with parecoxib versus 1.93 days with other anti-inflammatory drugs (p=0.008). Parecoxib has also significantly decreased hospitalization time for renal colic as compared to other drugs (25.2h versus 32.9h; p<0.001). CONCLUSION: Parecoxib sodium has provided shorter hospitalization time with possible decrease in use of resources and costs and should be considered a choice for such painful conditions.
id SBED-1_464ffa757672647ceecde5c54f4b80e5
oai_identifier_str oai:scielo:S1806-00132016000400294
network_acronym_str SBED-1
network_name_str Revista Dor
repository_id_str
spelling Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insuranceCyclooxygenase-2 inhibitorsHospitalizationParecoxibPostoperative periodRenal colicABSTRACT BACKGROUND AND OBJECTIVES: Adequate postoperative pain and renal colic control is critical for patients' recovery and to decrease hospitalization costs and the use of resources. So, this study aimed at evaluating hospitalization time of patients treated with parecoxib sodium versus other non-steroid anti-inflammatory drugs to manage postoperative pain of appendectomy or fractures and renal colic. METHODS: This is a retrospective data analysis of Brazilian private hospitals medical bills, including patients treated with non-steroid anti-inflammatory drugs to decrease post-appendectomy pain (n=1618), post orthopedic fracture pain (n=2858 and renal colic (n=6555), between January and June 2014. Mean hospitalization time was evaluated according to each group of drugs. Mean difference among groups was calculated by the Kruskal-Wallis method. RESULTS: Mean hospitalization time for patients submitted to appendectomy was 1.95 days with parecoxib versus 2.20 with other non-steroid anti-inflammatory drugs (p= 0.006). For patients submitted to orthopedic fracture surgery, mean time was 1.75 days with parecoxib versus 1.93 days with other anti-inflammatory drugs (p=0.008). Parecoxib has also significantly decreased hospitalization time for renal colic as compared to other drugs (25.2h versus 32.9h; p<0.001). CONCLUSION: Parecoxib sodium has provided shorter hospitalization time with possible decrease in use of resources and costs and should be considered a choice for such painful conditions.Sociedade Brasileira para o Estudo da Dor2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400294Revista Dor v.17 n.4 2016reponame:Revista Dorinstname:Sociedade Brasileira para o Estudo da Dor (SBED)instacron:SBED10.5935/1806-0013.20160092info:eu-repo/semantics/openAccessFerreira,Cristina NunesFahham,Lucas de VasconcelosSantana,Carlos Felipe Salgado deRio,João Carlos EliasMazza,Débora Dutra da SilveiraSquiassi,Haline Biancaeng2017-01-03T00:00:00Zoai:scielo:S1806-00132016000400294Revistahttps://www.scielo.br/j/rdor/ONGhttps://old.scielo.br/oai/scielo-oai.phpdor@dor.org.br||dor@dor.org.br2317-63931806-0013opendoar:2017-01-03T00:00Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)false
dc.title.none.fl_str_mv Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
title Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
spellingShingle Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
Ferreira,Cristina Nunes
Cyclooxygenase-2 inhibitors
Hospitalization
Parecoxib
Postoperative period
Renal colic
title_short Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
title_full Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
title_fullStr Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
title_full_unstemmed Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
title_sort Impact of parecoxib on hospital discharge: retrospective analysis of Brazilian health insurance
author Ferreira,Cristina Nunes
author_facet Ferreira,Cristina Nunes
Fahham,Lucas de Vasconcelos
Santana,Carlos Felipe Salgado de
Rio,João Carlos Elias
Mazza,Débora Dutra da Silveira
Squiassi,Haline Bianca
author_role author
author2 Fahham,Lucas de Vasconcelos
Santana,Carlos Felipe Salgado de
Rio,João Carlos Elias
Mazza,Débora Dutra da Silveira
Squiassi,Haline Bianca
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Ferreira,Cristina Nunes
Fahham,Lucas de Vasconcelos
Santana,Carlos Felipe Salgado de
Rio,João Carlos Elias
Mazza,Débora Dutra da Silveira
Squiassi,Haline Bianca
dc.subject.por.fl_str_mv Cyclooxygenase-2 inhibitors
Hospitalization
Parecoxib
Postoperative period
Renal colic
topic Cyclooxygenase-2 inhibitors
Hospitalization
Parecoxib
Postoperative period
Renal colic
description ABSTRACT BACKGROUND AND OBJECTIVES: Adequate postoperative pain and renal colic control is critical for patients' recovery and to decrease hospitalization costs and the use of resources. So, this study aimed at evaluating hospitalization time of patients treated with parecoxib sodium versus other non-steroid anti-inflammatory drugs to manage postoperative pain of appendectomy or fractures and renal colic. METHODS: This is a retrospective data analysis of Brazilian private hospitals medical bills, including patients treated with non-steroid anti-inflammatory drugs to decrease post-appendectomy pain (n=1618), post orthopedic fracture pain (n=2858 and renal colic (n=6555), between January and June 2014. Mean hospitalization time was evaluated according to each group of drugs. Mean difference among groups was calculated by the Kruskal-Wallis method. RESULTS: Mean hospitalization time for patients submitted to appendectomy was 1.95 days with parecoxib versus 2.20 with other non-steroid anti-inflammatory drugs (p= 0.006). For patients submitted to orthopedic fracture surgery, mean time was 1.75 days with parecoxib versus 1.93 days with other anti-inflammatory drugs (p=0.008). Parecoxib has also significantly decreased hospitalization time for renal colic as compared to other drugs (25.2h versus 32.9h; p<0.001). CONCLUSION: Parecoxib sodium has provided shorter hospitalization time with possible decrease in use of resources and costs and should be considered a choice for such painful conditions.
publishDate 2016
dc.date.none.fl_str_mv 2016-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400294
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-00132016000400294
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1806-0013.20160092
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
publisher.none.fl_str_mv Sociedade Brasileira para o Estudo da Dor
dc.source.none.fl_str_mv Revista Dor v.17 n.4 2016
reponame:Revista Dor
instname:Sociedade Brasileira para o Estudo da Dor (SBED)
instacron:SBED
instname_str Sociedade Brasileira para o Estudo da Dor (SBED)
instacron_str SBED
institution SBED
reponame_str Revista Dor
collection Revista Dor
repository.name.fl_str_mv Revista Dor - Sociedade Brasileira para o Estudo da Dor (SBED)
repository.mail.fl_str_mv dor@dor.org.br||dor@dor.org.br
_version_ 1752126255449243648